| Bioactivity | SRT3109 is an antagonist of CXCR2, with a pIC50 of 8.2, and used in the research of chemokine mediated diseases. | ||||||||||||
| Invitro | SRT3109 (Example 1) is an antagonist of CXCR2, with a pIC50 of 8.2, and used in the research of chemokine mediated diseases[1]. | ||||||||||||
| Name | SRT3109 | ||||||||||||
| CAS | 1204707-71-0 | ||||||||||||
| Formula | C18H23F2N5O4S2 | ||||||||||||
| Molar Mass | 475.53 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Premji Meghani, et al. Pyrimidyl sulfonaminde derivative and its use for the treatment of chemokine mediated diseases. WO2010007427A1 |